Anne Mengel

1.2k total citations · 1 hit paper
18 papers, 967 citations indexed

About

Anne Mengel is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Anne Mengel has authored 18 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 10 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Anne Mengel's work include Chemical Synthesis and Analysis (3 papers), Microtubule and mitosis dynamics (3 papers) and Melanoma and MAPK Pathways (3 papers). Anne Mengel is often cited by papers focused on Chemical Synthesis and Analysis (3 papers), Microtubule and mitosis dynamics (3 papers) and Melanoma and MAPK Pathways (3 papers). Anne Mengel collaborates with scholars based in Germany, France and United States. Anne Mengel's co-authors include Oliver Reiser, Jörg Rademann, Günther Jung, Matthias Gaestel, K. Asadullah, Ulrich Bothe, Franz von Nussbaum, Dominik Mumberg, Gerhard Siemeister and Jens Schröder and has published in prestigious journals such as Chemical Reviews, Angewandte Chemie International Edition and Journal of Molecular Biology.

In The Last Decade

Anne Mengel

18 papers receiving 942 citations

Hit Papers

Around and beyond Cram's Rule 1999 2026 2008 2017 1999 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Mengel Germany 12 623 414 92 88 79 18 967
Hitesh J. Sanganee United Kingdom 23 741 1.2× 592 1.4× 113 1.2× 100 1.1× 64 0.8× 37 1.3k
Mark E. Schnute United States 19 715 1.1× 618 1.5× 53 0.6× 134 1.5× 102 1.3× 25 1.4k
V. Vinader United Kingdom 21 918 1.5× 360 0.9× 129 1.4× 113 1.3× 42 0.5× 48 1.2k
Dafydd R. Owen United Kingdom 19 596 1.0× 804 1.9× 57 0.6× 104 1.2× 44 0.6× 33 1.4k
Atli Thorarensen United States 24 1.2k 2.0× 749 1.8× 105 1.1× 156 1.8× 88 1.1× 45 2.0k
Kenneth J. Barr United States 12 717 1.2× 693 1.7× 72 0.8× 117 1.3× 49 0.6× 17 1.4k
Laurent Schio France 15 486 0.8× 344 0.8× 61 0.7× 76 0.9× 97 1.2× 29 1.0k
Randall W. Hungate United States 22 748 1.2× 643 1.6× 52 0.6× 141 1.6× 49 0.6× 51 1.4k
Tsunehiko Soga Japan 16 420 0.7× 307 0.7× 73 0.8× 207 2.4× 52 0.7× 36 711
Joseph S. Warmus United States 19 493 0.8× 448 1.1× 47 0.5× 113 1.3× 27 0.3× 38 962

Countries citing papers authored by Anne Mengel

Since Specialization
Citations

This map shows the geographic impact of Anne Mengel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Mengel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Mengel more than expected).

Fields of papers citing papers by Anne Mengel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Mengel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Mengel. The network helps show where Anne Mengel may publish in the future.

Co-authorship network of co-authors of Anne Mengel

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Mengel. A scholar is included among the top collaborators of Anne Mengel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Mengel. Anne Mengel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lefranc, Julien, Volker Schulze, R.C. Hillig, et al.. (2019). Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor. Journal of Medicinal Chemistry. 63(2). 601–612. 32 indexed citations
2.
Siemeister, Gerhard, Anne Mengel, Amaury E. Fernández‐Montalván, et al.. (2018). Inhibition of BUB1 Kinase by BAY 1816032 Sensitizes Tumor Cells toward Taxanes, ATR, and PARP Inhibitors In Vitro and In Vivo. Clinical Cancer Research. 25(4). 1404–1414. 53 indexed citations
3.
Siemeister, Gerhard, Anne Mengel, Wilhelm Bone, et al.. (2017). Abstract 287: BAY 1816032, a novel BUB1 kinase inhibitor with potent antitumor activity. Cancer Research. 77(13_Supplement). 287–287. 3 indexed citations
4.
Schubert, Conrad von, Fabien Cubizolles, Gerhard Siemeister, et al.. (2016). Probing the catalytic functions of Bub1 kinase using the small molecule inhibitors BAY-320 and BAY-524. eLife. 5. 49 indexed citations
5.
Bonin, Arne von, Alexandra Rausch, Anne Mengel, et al.. (2010). Inhibition of the IL-2-inducible tyrosine kinase (Itk) activity: a new concept for the therapy of inflammatory skin diseases. Experimental Dermatology. 20(1). 41–47. 36 indexed citations
6.
Schottelius, Arndt, Ulrich Zügel, Wolf‐Dietrich Döcke, et al.. (2009). The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in the p38/TNF-α Pathway of Systemic and Cutaneous Inflammation. Journal of Investigative Dermatology. 130(2). 481–491. 36 indexed citations
7.
Mengel, Anne, Oliver Reiser, & Jeffrey Aubé. (2008). Synthesis and structural study of cyclic 5-aminovaleric acid-linked β-Ala–β-Ala dipeptides. Bioorganic & Medicinal Chemistry Letters. 18(22). 5975–5977. 2 indexed citations
8.
Gaestel, Matthias, Anne Mengel, Ulrich Bothe, & K. Asadullah. (2007). Protein Kinases as Small Molecule Inhibitor Targets in Inflammation. Current Medicinal Chemistry. 14(21). 2214–2234. 78 indexed citations
9.
Hillig, R.C., Uwe Eberspaecher, Felipe S. Monteclaro, et al.. (2007). Structural Basis for a High Affinity Inhibitor Bound to Protein Kinase MK2. Journal of Molecular Biology. 369(3). 735–745. 29 indexed citations
10.
Blume, Thorsten, Judith Günther, R.C. Hillig, et al.. (2004). Design and synthesis of macrocyclic inhibitors of phosphatase Cdc25B. Bioorganic & Medicinal Chemistry Letters. 14(7). 1673–1677. 21 indexed citations
11.
Blume, Thorsten, et al.. (2004). Novel macrocyclic templates by ring enlargement of ansa-steroids. Tetrahedron Letters. 45(52). 9569–9571. 7 indexed citations
12.
Blume, Thorsten, Anne Mengel, Werner Skuballa, et al.. (2003). From Rigidity to Conformational Flexibility: Macrocyclic Templates Derived from ansa‐Steroids. Angewandte Chemie International Edition. 42(33). 3961–3964. 18 indexed citations
13.
Blume, Thorsten, Anne Mengel, Werner Skuballa, et al.. (2003). Von Rigidität zu konformativer Flexibilität: makrocyclische Template, abgeleitet von Ansa‐Steroiden. Angewandte Chemie. 115(33). 4091–4094. 8 indexed citations
17.
Mengel, Anne & Oliver Reiser. (1999). Around and beyond Cram's Rule. Chemical Reviews. 99(5). 1191–1224. 454 indexed citations breakdown →
18.
Mengel, Anne, et al.. (1984). Cis/trans isomerization in cured, black‐reinforced, high cis‐1,4‐polybutadiene. Journal of Polymer Science Polymer Chemistry Edition. 22(3). 843–846. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026